Viewing Study NCT02978261


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2025-12-27 @ 9:55 PM
Study NCT ID: NCT02978261
Status: COMPLETED
Last Update Posted: 2020-03-04
First Post: 2016-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas
Sponsor: Beijing Pearl Biotechnology Limited Liability Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-09
Start Date Type: ACTUAL
Primary Completion Date: 2018-04
Primary Completion Date Type: ACTUAL
Completion Date: 2018-12
Completion Date Type: ACTUAL
First Submit Date: 2016-11-28
First Submit QC Date: None
Study First Post Date: 2016-11-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-03-02
Last Update Post Date: 2020-03-04
Last Update Post Date Type: ACTUAL